1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distinct effects of Q925 mutation on intracellular and extracellular Na + and K + binding to the Na +, K +-ATPase

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Three Na + sites are defined in the Na +-bound crystal structure of Na +, K +-ATPase. Sites I and II overlap with two K + sites in the K +-bound structure, whereas site III is unique and Na + specific. A glutamine in transmembrane helix M8 (Q925) appears from the crystal structures to coordinate Na + at site III, but does not contribute to K + coordination at sites I and II. Here we address the functional role of Q925 in the various conformational states of Na +, K +-ATPase by examining the mutants Q925A/G/E/N/L/I/Y. We characterized these mutants both enzymatically and electrophysiologically, thereby revealing their Na + and K + binding properties. Remarkably, Q925 substitutions had minor effects on Na + binding from the intracellular side of the membrane – in fact, mutations Q925A and Q925G increased the apparent Na + affinity – but caused dramatic reductions of the binding of K + as well as Na + from the extracellular side of the membrane. These results provide insight into the changes taking place in the Na +-binding sites, when they are transformed from intracellular- to extracellular-facing orientation in relation to the ion translocation process, and demonstrate the interaction between sites III and I and a possible gating function of Q925 in the release of Na + at the extracellular side.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          High-efficiency transformation of mammalian cells by plasmid DNA.

          We describe a simple calcium phosphate transfection protocol and neo marker vectors that achieve highly efficient transformation of mammalian cells. In this protocol, the calcium phosphate-DNA complex is formed gradually in the medium during incubation with cells and precipitates on the cells. The crucial factors for obtaining efficient transformation are the pH (6.95) of the buffer used for the calcium phosphate precipitation, the CO2 level (3%) during the incubation of the DNA with the cells, and the amount (20 to 30 micrograms) and the form (circular) of DNA. In sharp contrast to the results with circular DNA, linear DNA is almost inactive. Under these conditions, 50% of mouse L(A9) cells can be stably transformed with pcDneo, a simian virus 40-based neo (neomycin resistance) marker vector. The NIH3T3, C127, CV1, BHK, CHO, and HeLa cell lines were transformed at efficiencies of 10 to 50% with this vector and the neo marker-incorporated pcD vectors that were used for the construction and transduction of cDNA expression libraries as well as for the expression of cloned cDNA in mammalian cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure-function relationships in the Na,K-ATPase alpha subunit: site-directed mutagenesis of glutamine-111 to arginine and asparagine-122 to aspartic acid generates a ouabain-resistant enzyme.

            Na,K-ATPases from various species differ greatly in their sensitivity to cardiac glycosides such as ouabain. The sheep and human enzymes are a thousand times more sensitive than the corresponding ones from rat and mouse. To define the region of the alpha 1 subunit responsible for this differential sensitivity, chimeric cDNAs of sheep and rat were constructed and expressed in ouabain-sensitive HeLa cells. The construct containing the amino-terminal half of the rat alpha 1 subunit coding region and carboxyl-terminal half of the sheep conferred the ouabain-resistant phenotype to HeLa cells while the reverse construct did not. This indicates that the determinants involved in ouabain sensitivity are located in the amino-terminal half of the Na,K-ATPase alpha subunit. By use of site-directed mutagenesis, the amino acid sequence of the first extracellular domain (H1-H2) of the sheep alpha 1 subunit, Gln-Ala-Ala-Thr-Glu-Glu-Glu-Pro-Gln-Asn-Asp-Asn, was changed to that of the rat, Arg-Ser-Ala-Thr-Glu-Glu-Glu-Pro-Pro-Asn-Asp-Asp. When expressed in HeLa cells, this mutated sheep alpha 1 construct, like the rat/sheep chimera, was able to confer ouabain resistance to these cells. Furthermore, similar results were observed when HeLa cells were transfected with a sheep alpha 1 cDNA containing only two amino acid substitutions. This double mutation was a Gln-111----Arg and Asn-122----Asp change at the amino terminus and carboxyl terminus, respectively, of the H1-H2 extracellular region. The resistant cells, whether transfected with the rat alpha 1 cDNA, the rat/sheep chimera, or the mutant sheep alpha 1 cDNAs, exhibited identical biochemical characteristics including ouabain-inhibitable cell growth, 86Rb+ uptake, and Na,K-ATPase activity.(ABSTRACT TRUNCATED AT 250 WORDS)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine.

              Hemiplegic migraine (HM) is a rare subtype of migraine with aura that may occur as a familial (FHM) or sporadic condition (SHM). Screening of FHM genes in previous series of patients with SHM detected a very low proportion of mutated patients. In this study, we investigated the FHM genes in patients with an early onset sporadic form of HM (onset before 16 years). Twenty-five patients were included. Each one and his or her 2 parents were blood sampled. Mean age at diagnosis was 14.7 ± 8.2 years and mean age at clinical onset was 7.7 ± 3.4 years. Sequencing of ATP1A2 and CACNA1A was conducted in each proband and all identified variants were looked for in both parents. SCN1A was screened in all patients without CACNA1A or ATP1A2 de novo mutation. Twenty-three different amino acid variants were identified in 23 of the 25 patients. The variants occurred de novo in 19 patients (76%), strongly in favor of their causal role. SCN1A analysis did not show any mutation. Among the 19 patients with a de novo mutation, 5 had a pure HM and 14 had associated neurologic signs such as ataxia, epilepsy, or intellectual disabilities. FHM genes are involved in early-onset SHM, in particular when associated with neurologic signs. Molecular analysis can be helpful in those cases. Our study identified 14 novel de novo mutations that will help to interpret genetic tests in molecular diagnosis practice.
                Bookmark

                Author and article information

                Contributors
                pablo.artigas@ttuhsc.edu
                bv@biomed.au.dk
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                16 September 2019
                16 September 2019
                2019
                : 9
                : 13344
                Affiliations
                [1 ]ISNI 0000 0001 1956 2722, GRID grid.7048.b, Department of Biomedicine, , Aarhus University, ; DK-8000 Aarhus C, Denmark
                [2 ]ISNI 0000 0001 2179 3554, GRID grid.416992.1, Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, , Texas Tech University Health Sciences Center, ; Lubbock, TX 79430 USA
                Author information
                http://orcid.org/0000-0003-0654-4300
                http://orcid.org/0000-0002-6893-9765
                http://orcid.org/0000-0002-4727-9382
                Article
                50009
                10.1038/s41598-019-50009-2
                6746705
                31527711
                1358c5ad-9ed3-4e3c-a077-25abddfdf42d
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 17 May 2019
                : 3 September 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000001, National Science Foundation (NSF);
                Award ID: MCB-1515434
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100004836, Det Frie Forskningsråd (Danish Council for Independent Research);
                Award ID: 7016-00193B
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100003554, Lundbeckfonden (Lundbeck Foundation);
                Award ID: R223-2016-595
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100009708, Novo Nordisk Fonden (Novo Nordisk Foundation);
                Award ID: NNF14OC0013409
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100006309, Riisfort Fonden (Riisfort Foundation);
                Award ID: 05052015
                Award Recipient :
                Funded by: Toyota Foundation Denmark, Grant 8970-F
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                permeation and transport,enzyme mechanisms
                Uncategorized
                permeation and transport, enzyme mechanisms

                Comments

                Comment on this article